What are the pregnancy risks and recommended contraceptive options for women with a Fontan circulation after repair of hypoplastic left heart syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pregnancy Risks and Contraception in Women with Fontan Circulation

Women with Fontan circulation face extremely high pregnancy risks (WHO Class III-IV) and must avoid estrogen-containing contraceptives due to thrombotic risk; progesterone-only methods, intrauterine devices, or permanent sterilization are the safest contraceptive options.

Pregnancy Risks: High Maternal and Fetal Morbidity

Women with Fontan physiology carry substantial pregnancy risks that warrant intensive preconception counseling. The 2018 AHA/ACC guidelines explicitly classify Fontan patients as high-risk, noting they have "extremely high risk of maternal mortality or severe morbidity" 1. The ESC guidelines similarly advise careful counseling, noting these are WHO Class III or IV pregnancies 2.

Maternal Complications

The hemodynamic burden of pregnancy is poorly tolerated in Fontan circulation:

  • Cardiac decompensation occurs in approximately 50% of pregnancies, with some requiring hospitalization 3
  • Arrhythmias (particularly atrial flutter and supraventricular tachycardia) complicate many pregnancies 4, 3
  • Thrombotic events remain a significant concern given the prothrombotic state of both pregnancy and Fontan physiology 2, 4
  • Heart failure can develop or worsen, particularly in those with pre-existing ventricular dysfunction 1

Recent data shows that while acute complications during pregnancy are common, medium-term functional decline may be limited in selected patients 5. However, ejection fraction can worsen post-pregnancy more than in matched controls 5.

Fetal and Obstetric Complications

The fetal outcomes are sobering:

  • Miscarriage rate: 50-53% across multiple studies 4, 3, 6
  • Preterm delivery is common, with mean gestational age around 33-36 weeks 4, 3, 6
  • Low birth weight (mean ~2,086-2,344g) 4, 6
  • Small for gestational age infants occur frequently 2, 7
  • Obstetric complications (particularly bleeding) affect nearly half of pregnancies 5

High-Risk Features Contraindicating Pregnancy

The guidelines identify specific features that should lead to strong counseling against pregnancy 1, 2:

  • Oxygen saturation <85% at rest
  • Significant ventricular dysfunction (EF <40%)
  • NYHA Class III-IV symptoms
  • Moderate to severe atrioventricular valve regurgitation
  • Protein-losing enteropathy
  • Non-optimal Fontan circuit

If pregnancy occurs in these high-risk patients, pregnancy termination should be discussed 1.

Contraceptive Recommendations: Avoid Estrogen

Contraindicated: Estrogen-Containing Methods

The 2018 AHA/ACC guidelines provide a Class III (Harm) recommendation against estrogen-containing contraceptives in Fontan patients 1. Fontan physiology is explicitly listed as a high thrombotic risk state where estrogen is potentially harmful. This is non-negotiable given the already elevated thrombotic risk in these patients.

Real-world data supports this concern: among 138 women with Fontan circulation, 6 experienced thrombotic complications, though only one was using oral contraceptives 4. The baseline thrombotic risk is substantial even without estrogen exposure.

Recommended Contraceptive Options

Given the high pregnancy risks and contraindication to estrogen, highly effective non-estrogen contraception is essential 1:

First-Line Options:

  1. Intrauterine devices (IUDs) - Highly effective with no thrombotic risk

    • Caveat: Risk of vasovagal reaction at insertion; consider prophylactic atropine and placement in a monitored setting 1
    • Both copper and levonorgestrel IUDs are appropriate
  2. Progesterone-only methods:

    • Progesterone-only pills (though require strict adherence)
    • Progestin implants (etonogestrel)
    • Note: Medroxyprogesterone acetate (Depo-Provera) is less effective and carries fluid retention risk, making it less ideal 1
  3. Permanent sterilization:

    • Tubal ligation (with careful anesthetic planning given cardiac risk) 1
    • Partner vasectomy may be the safest option, though the patient's long-term prognosis must be considered in this decision 1

Less Reliable Options:

  • Barrier methods alone have high failure rates (~12% use in one cohort) 4
  • Notably, 44% of women in one study used no contraception 4, highlighting the critical need for proactive counseling

Critical Counseling Points

All women of childbearing age with Fontan circulation require comprehensive contraceptive counseling that includes 1:

  • Expected failure rates of each method
  • Maternal and fetal risks of unplanned pregnancy (50% miscarriage rate, high maternal morbidity)
  • The specific contraindication to estrogen-containing methods
  • Regular reassessment of contraceptive needs

Anticoagulation Considerations

The ESC guidelines suggest anticoagulation should be considered during pregnancy in Fontan patients (Class IIa) 2. For contraception counseling, this means:

  • Women already on warfarin face additional complexity, as the interaction between warfarin and estrogen-containing contraceptives is unclear 1
  • This does not make estrogen safe—it remains contraindicated
  • Prophylactic anticoagulation may be needed during pregnancy itself, particularly with assisted reproductive technology 8

Special Consideration: Assisted Reproductive Technology

For women pursuing fertility treatment, additional thrombotic risk from ovarian stimulation must be considered, with prophylactic anticoagulation (enoxaparin) recommended during stimulation cycles 8.

Clinical Algorithm for Contraceptive Selection

  1. Confirm Fontan physiology → Estrogen contraceptives are absolutely contraindicated
  2. Assess patient preferences and compliance ability:
    • High compliance → Progesterone-only pills acceptable
    • Prefer long-acting → IUD or implant (first choice)
    • Completed childbearing → Consider permanent sterilization
  3. Pre-IUD insertion: Plan for monitored setting with atropine available
  4. Avoid Depo-Provera due to fluid retention risk in this population
  5. Document counseling regarding 50% miscarriage risk and maternal morbidity if pregnancy occurs

Preconception Planning If Pregnancy Desired

For the rare patient with favorable features (younger age, normal weight, no functional limitation, good ventricular function, no Fontan complications) who desires pregnancy 9:

  • Multidisciplinary pregnancy heart team evaluation before conception 8
  • Cardiopulmonary exercise testing to assess functional capacity 1
  • Detailed echocardiographic assessment of ventricular function and valve regurgitation
  • Discussion of 50% miscarriage rate and high preterm delivery risk
  • Plan for therapeutic anticoagulation during pregnancy 2
  • Delivery at tertiary center with frequent monitoring (every 4 weeks) 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.